Status:

RECRUITING

Embryo Health Study

Lead Sponsor:

Genomic Prediction Inc.

Conditions:

Infertility

Hereditary Diseases

Eligibility:

All Genders

18+ years

Brief Summary

This study intends to determine the patients' perception and motivation to obtain additional information on their preimplantation embryos' risks of polygenic disorders. Patients undergoing IVF and gen...

Detailed Description

Patients planning to use PGT-A and who meet the inclusion criteria will be offered participation by their IVF physician prior to initiating cycle stimulation. Eligible and interested patients will be ...

Eligibility Criteria

Inclusion

  • All couples of Caucasian or East Asian ancestry above the age of 18 who elect to have PGT-A as part of their IVF treatment cycle.

Exclusion

  • Any case where biological parental DNA is unavailable.
  • Any case involving PGT-M or PGT-SR.

Key Trial Info

Start Date :

December 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT04528498

Start Date

December 1 2020

End Date

December 1 2025

Last Update

August 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Genomic Prediction Clinical Laboratory

North Brunswick, New Jersey, United States, 08902

Embryo Health Study | DecenTrialz